BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Noxopharm CEO Discusses SOF-VAC™, a Promising Vaccine Enhancer for mRNA Vaccines

In an interaction with BioPharma APAC, Noxopharm CEO Dr. Gisela Mautner discussed the company's newly announced proprietary product candidate, SOF-VAC&trad...

March 31, 2023 | Influencers

Noxopharm Announces Novel mRNA Vaccine Enhancer

Proprietary SOF-VACTM asset with potential to make mRNA vaccines safer, better tolerated by patients and more cost-effective to manufacture Preclin...

March 28, 2023 | News

Indian Immunologicals Limited receives regulatory approval for Measles-Rubella (MR) Vaccine

Indian Immunologicals Limited (IIL), a leading vaccine manufacturer has announced receipt of approval from Drugs Controller General of India and State...

March 28, 2023 | News

YS Biopharma's PIKA COVID-19 Vaccine Shows Better Antibody Response Than Inactivated Vaccine in Phase II Study

The trial met its primary endpoint of superior immunogenicity of PIKA COVID-19 Vaccine vs inactivated COVID-19 vaccine, measured by GMT of neutralizing a...

March 28, 2023 | News

Etana has secured financing from Deg, East Ventures and other global investors

Etana is committed to build production capacity for mammalian cell for monoclonal antibodies drug substance to ensure high local content production a...

March 20, 2023 | News

China's first personalized neoantigen-targeted cancer vaccine receives NMPA's clinical trial approval

On December 22, 2022, Likang submitted an IND application for LK101 Injection to NMPA, and received application shortly after. LK101 Injection, the fi...

March 17, 2023 | News

Everest Medicines Commences Operations at State-of-the-Art mRNA Vaccine Facility.

Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercializa...

February 28, 2023 | News

SK bioscience’s Shingles Vaccine Secures the Highest Market Share in South Korea

‘SKYZoster®, ' the world second developed shingles vaccine secures 54% of the South Korean market share With proven immunogenicity and s...

February 28, 2023 | News

GenScript ProBio and RVAC Medicines Partner for COVID-19 Vaccine Plasmid DNA Manufacturing

GenScript ProBio will provide GMP plasmid manufacturing service for RVAC Medicines' program, RVM-V001. This partnership will enable to accelerate its clini...

February 23, 2023 | News

Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China

-- Clover to leverage its established and growing commercial infrastructure to exclusively distribute Adimmune’s AdimFlu-S (QIS), the only imported q...

February 20, 2023 | News

U.S. Government and Novavax Extend Partnership

Modified agreement also includes the development of an updated vaccine in fall 2023 Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to...

February 14, 2023 | News

GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea

This plant is the largest filling and finish facility based in South Korea, established in 2019. GC Biopharma installed an isolator facilities and app...

February 09, 2023 | News

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering

Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights. Expands o...

January 31, 2023 | News

Moderna Granted FDA Breakthrough Therapy Designation for Mrna-1345, an Investigational Respiratory Syncytial Virus (Rsv) Vaccine Candidate

 Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced mRNA-1345, an investig...

January 30, 2023 | News

Stay Connected